Sorrento Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2015 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2015 to Q2 2023.
  • Sorrento Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 551M shares, a 36.9% increase year-over-year.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 419M shares, a 42.3% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 295M shares, a 28.3% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 230M shares, a 73.1% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 551M +148M +36.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 543M +206M +61.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 419M +110M +35.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 452M +152M +50.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 403M +113M +38.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 337M +56.5M +20.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 309M +41M +15.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 299M +48.1M +19.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 290M +73M +33.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 281M +98M +53.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 268M +113M +72.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 251M +120M +92.1% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 217M +94.4M +77% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 183M +60.3M +49.3% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
Q4 2019 155M +33.4M +27.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 131M +13.8M +11.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-19
Q2 2019 123M +22M +21.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-19
Q1 2019 122M +37.3M +44% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-19
Q4 2018 122M +41.1M +51% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 117M +40.1M +52.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 101M +30.3M +43% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 84.9M +34.1M +66.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 80.5M +21.9M +37.3% Oct 1, 2017 Dec 31, 2017 8-K 2019-06-17
Q3 2017 76.9M +10.7M +16.2% Jul 1, 2017 Sep 30, 2017 8-K 2019-06-17
Q2 2017 70.3M +23.8M +51.2% Apr 1, 2017 Jun 30, 2017 8-K 2019-06-17
Q1 2017 50.9M +12.9M +34% Jan 1, 2017 Mar 31, 2017 8-K 2019-06-17
Q4 2016 58.6M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 66.2M +66.2M +177228% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 46.5M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 38M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q3 2015 37.3K* Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.